GlassScriptPhysician profile
Melissa R Sieber
NPI 1619389293
$5,569.18
in general payments reported to CMS, 2019-2025
29 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what 79% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $402 · 2021: $455 · 2022: $723 · 2023: $1,046 · 2024: $967 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,113.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,347.47 | 2019-2025 | Clareon, Tryptyr, Clareon Panoptix Pro |
| Abbvie INC. | $552.98 | 2022-2025 | Alphagan P, Lumigan, Vuity |
| Merz North America, INC. | $363.99 | 2019 | |
| Sun Pharmaceutical Industries INC. | $286.51 | 2019-2025 | Cequa |
| Rxsight INC | $265.81 | 2023-2025 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Dompe US, INC. | $238.27 | 2021-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $161.53 | 2022-2023 | Tecnis Iol, Tecnis Simplicity |
| Harrow Eye, LLC | $160.58 | 2024-2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $157.44 | 2019-2021 | |
| Amgen INC. | $122.17 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $112.45 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Oyster Point Pharma, INC. | $110.08 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $103.65 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $83.76 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $69.91 | 2019-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $56.32 | 2022-2024 | Omni Surgical System |
| Shire North American Group INC | $46.76 | 2019 | |
| Thea Pharma INC. | $46.41 | 2023-2025 | Iyuzeh |
| Allergan, INC. | $44.74 | 2019-2020 | |
| Omeros Corporation | $38.19 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $35.73 | 2019-2020 | |
| Carl Zeiss Meditec USA, INC. | $27.62 | 2024 | Cirrus Hd-Oct |
| Kala Pharmaceuticals, INC. | $22.87 | 2019 | |
| Glaukos Corporation | $21.97 | 2025 | Idosetr |
| Ocular Therapeutix, INC. | $21.71 | 2025 | Dextenza |
| Biotissue Holdings INC. | $21.39 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rayner Intraocular Lenses Limited | $17.30 | 2022 | |
| Eyevance Pharmaceuticals LLC | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Sieber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.